Lead Pharma Teams with Roche on Oral Small Molecules for Immune-Mediated Diseases
The Pharma Data
NOVEMBER 17, 2020
Lead Pharma has entered into a collaboration and license agreement with Roche , hoping to lead the way in the development of oral small molecules for immune-mediated diseases like rheumatoid arthritis, psoriasis and inflammatory bowel diseases. . Humans as well as cats and dogs can be affected. .
Let's personalize your content